Suchergebnisse - "Wang, Qixue"

PubPharm (9)

1

EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma

enthalten in: Cancer letters | 2024

von Yang, E. | Hong, B. | Wang, Y. | +8

2

EPIC-1042 as a potent PTRF/Cavin1-caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma

enthalten in: Neuro-oncology | 2024

von Hong, B. | Yang, E. | Su, D. | +15

ErratumIn: Neuro Oncol. 2023 Dec 8;25(12):2306-2308. - PMID 37931238

3

Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma

enthalten in: Cancer communications (London, England) | 2023

von Cui, X. | Zhao, J. | Li, G. | +15

4

EPIC-0307-mediated selective disruption of PRADX-EZH2 interaction and enhancement of temozolomide sensitivity to glioblastoma via inhibiting DNA repair and MGMT

enthalten in: Neuro-oncology | 2023

von Xin, L. | Tan, Y. | Zhu, Y. | +12

5

Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance

enthalten in: Cancer biology & medicine | 2023

von Zhou, J. | Tong, F. | Zhao, J. | +6

6

A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastoma

enthalten in: Neuro-oncology | 2023

von Zhao, J. | Yang, S. | Cui, X. | +9

7

Expert opinion on translational research for advanced glioblastoma treatment

enthalten in: Cancer biology & medicine | 2023

von Cui, X. | Wang, Y. | Zhou, J. | +2

8

PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma

enthalten in: Theranostics | 2022

von Yang, E. | Wang, L. | Jin, W. | +13

9

PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma

enthalten in: Cancer letters | 2019

von Zhang, Z. | Wang, Z. | Huang, K. | +10

1
[1]